We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology

News   Nov 28, 2017

 
SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology
 
 
Advertisement
 

RELATED ARTICLES

Fighting COVID-19 With the Help of High-performance Computing

News

OCF is assisting its customers to get involved in “Folding@home” in the fight against COVID-19.

READ MORE

Linking Biological Molecules to Fatty Acids To Aid Drug Delivery

News

Houston Methodist researchers have designed a platform where a diabetes drug is chemically linked to fatty acids and then packaged in a nanoparticle resistant to the stomach’s gastric acids.

READ MORE

Molding Matter at the Molecular Level

News

Scientists used a focused beam of electrons to stitch platinum-silicon molecules into graphene, marking the first deliberate insertion of artificial molecules into a graphene host matrix.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Applied Sciences Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE